MENU

TRIB Stock Tickeron detected bearish Stock Pattern: Triangle Symmetrical Top TRIB on October 15, 2025, netting in a 27.52% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+27.52% Gain from a Successful pattern Triangle Symmetrical Top
TRIB - Trinity Biotech plc
Tickeron
Ticker: TRIB
Company: Trinity Biotech plc
Gain from shorting: +27.52%
Confirmed: 10/15/25
Succeeded: 11/17/25
Total length: 39 days

On October 09, 2025, A.I.dvisor detected a Triangle Symmetrical Top Pattern (Bearish) for Trinity Biotech plc (TRIB, $1.13). 6 days later, on October 15, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 17, 2025, the stock hit the target price of $0.83 – resulting in a +2 gain for traders who shorted the stock on the pattern detection date.

Momentum Indicator for TRIB turns negative, indicating new downward trend

TRIB saw its Momentum Indicator move below the 0 level on November 07, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TRIB entered a downward trend on November 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TRIB's RSI Indicator exited the oversold zone, of 49 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRIB advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRIB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (63.026). P/E Ratio (0.562) is within average values for comparable stocks, (36.228). TRIB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.720). TRIB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.273) is also within normal values, averaging (84.164).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
TRIB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a devloper of medical diagnostic products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
IDA Business Park
Phone
+353 12769800
Employees
398
Web
https://www.trinitybiotech.com